References
1. Chow EJ, Anderson L, Baker KS, et al. Late effects surveillance
recommendations among survivors of childhood hematopoietic cell
transplantation: a Children’s Oncology Group report. Biology of
Blood and Marrow Transplantation. 2016;22(5):782-795.
2. Yen H-J, Eissa H, Bhatt NS, et al. Patient-Reported Outcomes in
Survivors of Childhood Hematologic Malignancies with Hematopoietic Stem
Cell Transplant. Blood Journal. 2020:blood. 2019003858.
3. Buchbinder D, Kelly DL, Duarte RF, et al. Neurocognitive dysfunction
in hematopoietic cell transplant recipients: expert review from the late
effects and Quality of Life Working Committee of the CIBMTR and
complications and Quality of Life Working Party of the EBMT. Bone
marrow transplantation. 2018;53(5):535-555.
4. Kadan-Lottick NS, Zeltzer LK, Liu Q, et al. Neurocognitive
functioning in adult survivors of childhood non-central nervous system
cancers. JNCI: Journal of the National Cancer Institute.2010;102(12):881-893.
5. Ellenberg L, Liu Q, Gioia G, et al. Neurocognitive status in
long-term survivors of childhood CNS malignancies: a report from the
Childhood Cancer Survivor Study. Neuropsychology. 2009;23(6):705.
6. Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR.
Neurocognitive outcomes and interventions in long-term survivors of
childhood cancer. Journal of Clinical Oncology. 2018;36(21):2181.
7. Iyer NS, Balsamo LM, Bracken MB, Kadan-Lottick NS. Chemotherapy-only
treatment effects on long-term neurocognitive functioning in childhood
ALL survivors: a review and meta-analysis. Blood.2015;126(3):346-353.
8. Brinkman TM, Krasin MJ, Liu W, et al. Long-term neurocognitive
functioning and social attainment in adult survivors of pediatric CNS
tumors: results from the St Jude Lifetime Cohort Study. Journal of
Clinical Oncology. 2016;34(12):1358.
9. Krull KR, Annett RD, Pan Z, et al. Neurocognitive functioning and
health-related behaviours in adult survivors of childhood cancer: a
report from the Childhood Cancer Survivor Study. European Journal
of Cancer. 2011;47(9):1380-1388.
10. Barrera M, Atenafu E. Cognitive, educational, psychosocial
adjustment and quality of life of children who survive hematopoietic SCT
and their siblings. Bone marrow transplantation.2008;42(1):15-21.
11. Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom
WM, van den Bent MJ. Cognitive functioning and quality of life in
long‐term adult survivors of bone marrow transplantation. Cancer.2002;95(1):183-192.
12. Phipps S, Rai SN, Leung W-H, Lensing S, Dunavant M. Cognitive and
academic consequences of stem-cell transplantation in children.Journal of clinical oncology. 2008;26(12):2027-2033.
13. Syrjala KL, Artherholt SB, Kurland BF, et al. Prospective
neurocognitive function over 5 years after allogeneic hematopoietic cell
transplantation for cancer survivors compared with matched controls at 5
years. Journal of clinical oncology. 2011;29(17):2397.
14. Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK. NCI,
NHLBI/PBMTC First International Conference on Late Effects after
Pediatric Hematopoietic Cell Transplantation: health-related quality of
life, functional, and neurocognitive outcomes. Biology of Blood
and Marrow Transplantation. 2012;18(2):162-171.
15. Kelly DL, Buchbinder D, Duarte RF, et al. Neurocognitive dysfunction
in hematopoietic cell transplant recipients: expert review from the Late
Effects and Quality of Life Working Committee of the Center for
International Blood and Marrow Transplant Research and Complications and
Quality of Life Working Party of the European Society for Blood and
Marrow Transplantation. Biology of Blood and Marrow
Transplantation. 2018;24(2):228-241.
16. Baker KS, Bhatia S, Bunin N, et al. NCI, NHLBI first international
consensus conference on late effects after pediatric hematopoietic cell
transplantation: state of the science, future directions. Biology
of Blood and Marrow Transplantation. 2011;17(10):1424-1427.
17. Lee SJ, Onstad L, Chow EJ, et al. Patient-reported outcomes and
health status associated with chronic graft-versus-host disease.haematologica. 2018;103(9):1535-1541.
18. Khera N, Chow EJ, Leisenring WM, et al. Factors associated with
adherence to preventive care practices among hematopoietic cell
transplantation survivors. Biology of blood and marrow
transplantation. 2011;17(7):995-1003.
19. Kenzik KM, Huang I, Brinkman TM, et al. The Childhood Cancer
Survivor Study–Neurocognitive Questionnaire (CCSS-NCQ) Revised: Item
response analysis and concurrent validity. Neuropsychology.2015;29(1):31.
20. Krull KR, Gioia G, Ness KK, et al. Reliability and validity of the
childhood cancer survivor study neurocognitive questionnaire.Cancer. 2008;113(8):2188-2197.
21. National Institute of Neurological Disorders and Stroke (NINDS).User Manual for the Quality of Life in Neurological Disorders
(Neuro-QoL) Measures, Version 2.0. 2015.
22. Yu L, Buysse DJ, Germain A, et al. Development of short forms from
the PROMIS™ sleep disturbance and sleep-related impairment item banks.Behavioral sleep medicine. 2012;10(1):6-24.
23. National Health and Nutrition Examination Survey. Audiometry.
https://wwwn.cdc.gov/nchs/data/nhanes/2011-2012/questionnaires/auq.pdf.
Published 2011. Accessed 06/01/2020.
24. Gabel N, Altshuler DB, Brezzell A, et al. Health related quality of
life in adult low and high-grade glioma patients using the national
institutes of health patient reported outcomes measurement information
system (PROMIS) and neuro-QOL assessments. Frontiers in
neurology. 2019;10:212.
25. Cheung YT, Brinkman TM, Li C, et al. Chronic health conditions and
neurocognitive function in aging survivors of childhood cancer: A report
from the Childhood Cancer Survivor Study. JNCI: Journal of the
National Cancer Institute. 2018;110(4):411-419.
26. Willard VW, Leung W, Huang Q, Zhang H, Phipps S. Cognitive outcome
after pediatric stem-cell transplantation: impact of age and total-body
irradiation. Journal of Clinical Oncology. 2014;32(35):3982.
27. Armstrong GT, Jain N, Liu W, et al. Region-specific radiotherapy and
neuropsychological outcomes in adult survivors of childhood CNS
malignancies. Neuro-oncology. 2010;12(11):1173-1186.
28. Armstrong GT, Liu Q, Yasui Y, et al. Long-term outcomes among adult
survivors of childhood central nervous system malignancies in the
Childhood Cancer Survivor Study. JNCI: Journal of the National
Cancer Institute. 2009;101(13):946-958.
29. Krull KR, Zhang N, Santucci A, et al. Long-term decline in
intelligence among adult survivors of childhood acute lymphoblastic
leukemia treated with cranial radiation. Blood, The Journal of the
American Society of Hematology. 2013;122(4):550-553.
30. Mueller S, Kline CN, Buerki RA, et al. Stroke impact on mortality
and psychologic morbidity within the Childhood Cancer Survivor Study.Cancer. 2020;126(5):1051-1059.
31. Clanton NR, Klosky JL, Li C, et al. Fatigue, vitality, sleep, and
neurocognitive functioning in adult survivors of childhood cancer: a
report from the Childhood Cancer Survivor Study. Cancer.2011;117(11):2559-2568.
32. Mulrooney DA, Ness KK, Neglia JP, et al. Fatigue and sleep
disturbance in adult survivors of childhood cancer: a report from the
childhood cancer survivor study (CCSS). Sleep.2008;31(2):271-281.
33. Children’s Oncology Group. Long-term follow-up guidelines for
survivors of childhood, adolescent and young adult cancers. .Children’s Oncology Group;2018.